International Biotechnology Trust (LSE:IBT) 3-Year Revenue Growth Rate : -47.20% (As of Feb. 2024)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust 3-Year Revenue Growth Rate?

International Biotechnology Trust's Revenue per Share for the six months ended in Feb. 2024 was £0.75.

During the past 12 months, International Biotechnology Trust's average Revenue per Share Growth Rate was -52.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -47.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of International Biotechnology Trust was 152.30% per year. The lowest was -47.20% per year. And the median was 4.80% per year.

Competitive Comparison of International Biotechnology Trust's 3-Year Revenue Growth Rate

For the Asset Management subindustry, International Biotechnology Trust's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust's 3-Year Revenue Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's 3-Year Revenue Growth Rate falls into.

International Biotechnology Trust 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

International Biotechnology Trust (LSE:IBT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

International Biotechnology Trust 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust (LSE:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

IBTl:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines